Vice President JD Vance announced in September 2026 that the Trump administration halted ACA enrollment for over 760,000 individuals believed to be fraudulently signed up, saving an estimated $2.2 billion

Policy, personnel, and politics of the Trump White House.

Evolving US policy battles over drug pricing and healthcare affordability, tracking legislation, court rulings, regulatory actions, and industry responses shaping costs, access, and market dynamics.